Clinical Trials Directory

Trials / Completed

CompletedNCT04488588

Survival and 30-days Hospital Outcome in COVID-19 Patients in Upper Egypt

Survival and 30-days Hospital Outcome in Hospitalized COVID-19 Patients in Upper Egypt: Multi-center Study

Status
Completed
Phase
Study type
Observational
Enrollment
1,064 (actual)
Sponsor
Assiut University · Academic / Other
Sex
All
Age
36 Years – 63 Years
Healthy volunteers

Summary

Through history, there have been plenty of pandemics however; the social response to corona virus disease (COVID-19) is unparalleled. It is assessed that almost four billion individuals are living in social segregation during this mother of all pandemics. Initially described in China in December 2019, severe acute respiratory syndrome caused by corona virus 2 (SARS-CoV-2) has spread all over the world and by 18th July 2020- there was an emergent figure of 13,824,739 confirmed cases and 591.666 losses reported to the WHO. To date, Egypt reported slightly over 82,000 confirmed COVID-19 cases with 3858 deaths. The new pandemic is injuring not only health organizations of several countries but also the financial prudence universal. Defining the clinical features and associated outcomes of patients diagnosed with coronavirus disease (COVID-19) is fundamental to improving our understanding and adequate management of this illness. Several articles have recently been published, describing the clinical features and outcomes of retrospective individuals with COVID-19

Conditions

Interventions

TypeNameDescription
OTHERKaplan Meier analysisKaplan Meier survival analysis was conducted to calculate the cumulative overall survival rates using Log Rank test for comparison between age groups

Timeline

Start date
2020-03-15
Primary completion
2020-05-01
Completion
2020-07-01
First posted
2020-07-28
Last updated
2020-07-28

Locations

2 sites across 1 country: Egypt

Source: ClinicalTrials.gov record NCT04488588. Inclusion in this directory is not an endorsement.